[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.21. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 28, 2004

Combined Antiretroviral Therapy During Pregnancy and Risk of Congenital Malformations

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(16):1961-1962. doi:10.1001/jama.291.16.1961-b

To the Editor: In their Research Letter, Dr De Santis and colleagues1 reported a possible association of infantile hemangiomas with combined antiretroviral therapy (CART) during pregnancy. As a control group, the authors identified all pregnancies in which the mother had contacted a teratology information service. There are numerous ways, however, in which these groups are not comparable, and which may thus confound the observed association. First, the control group was self-selected. Second, infantile hemangiomas are very common. Although their precise incidence is not known, estimates range from 4% to 10%.2 In addition, the increased frequency found in female and premature infants3 could easily have confounded the increase in the group treated with CART.

First Page Preview View Large
First page PDF preview
First page PDF preview
×